Association of allelic loss at 8p22 with poor prognosis among breast cancer cases treated with high-dose adjuvant chemotherapy

Cancer Letters

Volumn 180, Issue 1, 2002, Pages 75-82

  Tsuneizumi, Michiko ^a,b   Emi, Mitsuru ^a   Hirano, Akira ^a   Utada, Yoshihito ^a,c   Tsumagari, Koji ^a,c   Takahashi, Kaoru ^c   Kasumi, Fujio ^c   Akiyama, Futoshi ^c   Sakamoto, Goi ^c   Kazui, Teruhisa ^b   Nakamura, Yusuke ^d  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CANCER INSTITUTE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adjuvant chemotherapy; Breast cancer; Loss of heterozygosity; Postoperative prognosis; Tumor suppressor gene

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER TISSUE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 8P; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; FOLLOW UP; GENE LOSS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; POLYMORPHIC LOCUS; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; ALLELES; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; TIME FACTORS;

EID: 18344375053     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00010-1     Document Type: Article

References (41)

1. Allelotype of breast cancer: Cumulative allele losses promote tumor progression in primary breast cancer
2. Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations
3. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer
4. Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas
5. Detailed deletion mapping of chromosome arm 3p in breast cancers: A 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors
6. Mapping of breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21
7. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma
8. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer
9. Frequent allelic loss at the TOC locus on 17q25.1 in primary breast cancers
10. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1
11. Mapping of target regions of allelic loss in primary breast cancers to 1-cM intervals on genomic contigs at 6q21 and 6q25.3
12. Localization of breast cancer tumor-suppressor gene to a 3-cM interval within chromosomal region 16q22
13. Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer
14. Correlation of allelic loss with poor postoperative survival in breast cancer
15. Staging and prognostic factors
16. Prognostic factors and treatment decision in axillary node-negative breast cancer
17. The general rules for clinical and pathological recording of breast cancer
18. Cloning and characterization of human and mouse PROSC (proline synthetase co-transcribed) genes
19. A comprehensive genetic map of the human genome based on 5,264 microsatellites
20. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes
21. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer
22. Allelic loss of chromosomal arm 8p in breast cancer progression
23. Localization of chromosome 8p regions involved in early tumorigenesis of oral and laryngeal squamous carcinoma
24. Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer
25. Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas
26. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer
27. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype
28. Allelotype analysis of childhood acute lymphoblastic leukemia
29. Tumour-suppressor genes in prostatic oncogenesis: A positional approach
30. Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer
31. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer
32. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22
33. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene
34. PRLTS gene alterations in human prostate cancer
35. N-Acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions
36. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours
37. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer
38. Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2-Mb region of 8p22-p21.3
39. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer
40. Allelic loss at 8p22 region as prognostic factor in large and estrogen receptor-negative breast cancer
41. Loss of heterozygosity at 3p24-p25 as a prognostic factor in breast cancer